GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » Gross Margin %

Aarti Pharmalabs (BOM:543748) Gross Margin % : 49.95% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Aarti Pharmalabs's Gross Profit for the three months ended in Mar. 2024 was ₹2,527 Mil. Aarti Pharmalabs's Revenue for the three months ended in Mar. 2024 was ₹5,058 Mil. Therefore, Aarti Pharmalabs's Gross Margin % for the quarter that ended in Mar. 2024 was 49.95%.


The historical rank and industry rank for Aarti Pharmalabs's Gross Margin % or its related term are showing as below:

BOM:543748' s Gross Margin % Range Over the Past 10 Years
Min: 26.2   Med: 39.87   Max: 44.9
Current: 44.9


During the past 4 years, the highest Gross Margin % of Aarti Pharmalabs was 44.90%. The lowest was 26.20%. And the median was 39.87%.

BOM:543748's Gross Margin % is ranked worse than
54.56% of 986 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs BOM:543748: 44.90

Aarti Pharmalabs had a gross margin of 49.95% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Aarti Pharmalabs was 0.00% per year.


Aarti Pharmalabs Gross Margin % Historical Data

The historical data trend for Aarti Pharmalabs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Gross Margin % Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Gross Margin %
- 26.20 39.87 44.90

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.18 40.89 42.64 45.52 49.95

Competitive Comparison of Aarti Pharmalabs's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Pharmalabs's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Aarti Pharmalabs's Gross Margin % falls into.



Aarti Pharmalabs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Aarti Pharmalabs's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=8318.9 / 18526.1
=(Revenue - Cost of Goods Sold) / Revenue
=(18526.1 - 10207.2) / 18526.1
=44.90 %

Aarti Pharmalabs's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=2526.5 / 5057.7
=(Revenue - Cost of Goods Sold) / Revenue
=(5057.7 - 2531.2) / 5057.7
=49.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Aarti Pharmalabs  (BOM:543748) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Aarti Pharmalabs had a gross margin of 49.95% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Aarti Pharmalabs Gross Margin % Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs (BOM:543748) Business Description

Traded in Other Exchanges
Address
204, Udyog Kshetra, Mulund Goregaon Link Road, 2nd floor,, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives.

Aarti Pharmalabs (BOM:543748) Headlines

No Headlines